222 related articles for article (PubMed ID: 29666970)
21. High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children.
Gong J; Zhang H; Xing S; Li C; Ma Z; Jia G; Hu W
Cancer Biomark; 2014; 14(4):241-51. PubMed ID: 24934367
[TBL] [Abstract][Full Text] [Related]
22. [Clinical feature and surgical treatment of recurrent craniopharyngiomas].
Qi ST; Pan J; Zhang JL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1078-81. PubMed ID: 14559699
[TBL] [Abstract][Full Text] [Related]
23. Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature.
Schmalisch K; Beschorner R; Psaras T; Honegger J
Acta Neurochir (Wien); 2010 Feb; 152(2):313-9; discussion 319. PubMed ID: 19859655
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
[TBL] [Abstract][Full Text] [Related]
25. Gamma Knife surgery for craniopharyngioma: report on a 20-year experience.
Lee CC; Yang HC; Chen CJ; Hung YC; Wu HM; Shiau CY; Guo WY; Pan DH; Chung WY; Liu KD
J Neurosurg; 2014 Dec; 121 Suppl():167-78. PubMed ID: 25434950
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and prognosis of pediatric infradiaphragmatic craniopharyngioma relative to the tumor inflammatory response.
Peng J; Yang L; Pan J; Wang C; Nie J; Liu Y; Fan J; Zhou J; Qi S
Pediatr Res; 2021 Apr; 89(5):1119-1125. PubMed ID: 32559758
[TBL] [Abstract][Full Text] [Related]
27. Craniopharyngioma: a clinicopathological study of 141 cases.
Tavangar SM; Larijani B; Mahta A; Hosseini SM; Mehrazine M; Bandarian F
Endocr Pathol; 2004; 15(4):339-44. PubMed ID: 15681858
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of Growth Hormone Receptor Expression in Craniopharyngioma-Implications for Surgical Strategy.
Ogawa Y; Kudo M; Watanabe M; Tominaga T
World Neurosurg; 2020 Jun; 138():89-92. PubMed ID: 32059964
[TBL] [Abstract][Full Text] [Related]
29. Craniopharyngiomas in children: recurrence, reoperation and outcome.
Vinchon M; Dhellemmes P
Childs Nerv Syst; 2008 Feb; 24(2):211-7. PubMed ID: 17786455
[TBL] [Abstract][Full Text] [Related]
30. Surgical management of the recurrence and regrowth of craniopharyngiomas.
Minamida Y; Mikami T; Hashi K; Houkin K
J Neurosurg; 2005 Aug; 103(2):224-32. PubMed ID: 16175850
[TBL] [Abstract][Full Text] [Related]
31. Association of pituitary stalk management with endocrine outcomes and recurrence in microsurgery of craniopharyngiomas: A meta-analysis.
Li K; Lu X; Yang N; Zheng J; Huang B; Li L
Clin Neurol Neurosurg; 2015 Sep; 136():20-4. PubMed ID: 26056807
[TBL] [Abstract][Full Text] [Related]
32. [Two cases of craniopharyngioma associated with Rathke's cleft cyst].
Nakajou T; Morimoto M; Kurisaka M; Mori K
Noshuyo Byori; 1994; 11(1):85-92. PubMed ID: 8162156
[TBL] [Abstract][Full Text] [Related]
33. Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapies.
Hussain I; Eloy JA; Carmel PW; Liu JK
J Neurosurg; 2013 Jul; 119(1):106-12. PubMed ID: 23560577
[TBL] [Abstract][Full Text] [Related]
34. Immune Microenvironment of Primary and Recurrent Craniopharyngiomas: A Study of the Differences and Clinical Significance.
Lin D; Wang Y; Zhou Z; Lin Z
World Neurosurg; 2019 Jul; 127():e212-e220. PubMed ID: 30880197
[TBL] [Abstract][Full Text] [Related]
35. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
36. Extensive miRNA expression analysis in craniopharyngiomas.
Samis J; Vanin EF; Sredni ST; de Bonaldo Mde F; Costa FF; Tomita T; Habiby R; Zimmerman D; Soares MB
Childs Nerv Syst; 2016 Sep; 32(9):1617-24. PubMed ID: 27272948
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985-2005.
Pekmezci M; Louie J; Gupta N; Bloomer MM; Tihan T
Neurosurgery; 2010 Nov; 67(5):1341-9; discussion 1349. PubMed ID: 20871436
[TBL] [Abstract][Full Text] [Related]
38. Craniopharyngioma arising de novo in middle age. Case report.
Arginteanu MS; Hague K; Zimmerman R; Kupersmith MJ; Shaiu JH; Schaeffer J; Post KD
J Neurosurg; 1997 Jun; 86(6):1046-8. PubMed ID: 9171188
[TBL] [Abstract][Full Text] [Related]
39. Extended pterional approach for initial surgical management of craniopharyngiomas: a case series.
Tamasauskas A; Bunevicius A; Matukevicius A; Radziunas A; Urbonas M; Deltuva V
Turk Neurosurg; 2014; 24(2):174-83. PubMed ID: 24831357
[TBL] [Abstract][Full Text] [Related]
40. Pathology of craniopharyngiomas: clinical import of pathological findings.
Miller DC
Pediatr Neurosurg; 1994; 21 Suppl 1():11-7. PubMed ID: 7841069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
